102 related articles for article (PubMed ID: 6178362)
1. [Adjuvant chemotherapy with carminomycin and bleomycetin after radical surgery for squamous cell carcinoma of the lung (preliminary communication)].
Garin AM; Moroz LV; Prorokov VV; Chebotareva LI; Guznov GI
Antibiotiki; 1982 Mar; 27(3):202-5. PubMed ID: 6178362
[No Abstract] [Full Text] [Related]
2. Bleomycin, methotrexate, and streptozotocin in epidermoid carcinoma of the lung: an active drug combination with major nonhematologic toxicity.
Ihde DC; Cohen MH; Bunn PA; Bernath AM; Broder LE; Minna JD
Cancer Treat Rep; 1978 Jan; 62(1):155-7. PubMed ID: 75065
[No Abstract] [Full Text] [Related]
3. Effects of combination therapy with bleomycin (NSC-125066) and dibromodulcitol (NSC-104800) on squamous cell carcinoma in man.
Onuma T; Holland JF; Sako K; Shedd DP
Cancer Chemother Rep; 1972 Oct; 56(5):625-33. PubMed ID: 4119907
[No Abstract] [Full Text] [Related]
4. [Preliminary results of clinical evaluation of antineoplastic antibiotic bleomycetin].
Borisov VI; Ivanova VG; Dvorkina SIu
Antibiotiki; 1982 Mar; 27(3):205-6. PubMed ID: 6178363
[No Abstract] [Full Text] [Related]
5. Bleomycin (NSC-125066): phase I clinical study.
Sonntag RW
Cancer Chemother Rep; 1972 Apr; 56(2):197-205. PubMed ID: 4114485
[No Abstract] [Full Text] [Related]
6. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
7. Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer.
Rozencweig M; ten Bokkel Huinink W; Cavalli F; Bruntsch U; Dombernowsky P; Høst H; Bramwell V; Renard G; Van Glabbeke M; Decoster G
J Clin Oncol; 1984 Apr; 2(4):275-81. PubMed ID: 6584561
[TBL] [Abstract][Full Text] [Related]
8. [Phase I clinical study of MX2 (KRN 8602)].
Majima H
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):359-64. PubMed ID: 2310202
[TBL] [Abstract][Full Text] [Related]
9. Carminomycin (NSC-180024): a phase I study.
Abele R; Rozencweig M; Body JJ; Bedogni P; Reich SD; Crooke ST; Lenaz L; Kenis Y
Eur J Cancer (1965); 1980 Dec; 16(12):1555-9. PubMed ID: 7227430
[No Abstract] [Full Text] [Related]
10. [Treatment of epidermoid carcinoma of the oro-pharyngo-laryngeal area with combination of methotrexate and bleomycin].
Broquet MA; Jacot-Descombe E; Montandon A; Alberto P
Schweiz Med Wochenschr; 1974 Jan; 104(1):18-22. PubMed ID: 4128917
[No Abstract] [Full Text] [Related]
11. Clinical trial of rubidazone in advanced squamous cell carcinoma of the lung and adenocarcinoma of the large intestine.
Fraile RJ; Samson MK; Buroker TR; O'Bryan R; Baker LH; Vaitkevicius VK
Cancer Treat Rep; 1978 Oct; 62(10):1599-601. PubMed ID: 361229
[TBL] [Abstract][Full Text] [Related]
12. Available data from carminomycin studies in the United States: the acute intermittent intravenous schedule.
Comis RL; Ginsberg SJ; Reich SD; Baker LH; Crooke ST
Recent Results Cancer Res; 1981; 76():16-20. PubMed ID: 7232849
[No Abstract] [Full Text] [Related]
13. Phase I-II evaluation of carminomycin in adults with acute leukemia.
Debusscher L; Malarme M; Bron D; Rozencweig M; Stryckmans P
Eur J Cancer Clin Oncol; 1985 Jan; 21(1):31-4. PubMed ID: 3855751
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of the effect of methyl-CCNU (NSC-95441) on bronchogenic carcinoma.
Takita H; Brugarolas A; Mittelman A; Vincent R
Cancer Chemother Rep 3; 1973 Mar; 4(2):257-9. PubMed ID: 4125743
[No Abstract] [Full Text] [Related]
15. [Perioperative adjuvant chemotherapy with bleomycin in bronchogenic squamous cell cancer. A prospective randomized study].
Jüttner FM; Smolle J; Popper H; Pinter HH; Friehs G
Onkologie; 1986 Oct; 9(5):250-3. PubMed ID: 2433653
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical study of carminomycin: its activity against soft tissue sarcomas.
Perevodchikova NI; Lichinitser MR; Gorbunova VA
Cancer Treat Rep; 1977 Dec; 61(9):1705-7. PubMed ID: 340034
[No Abstract] [Full Text] [Related]
17. Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
Caradonna R; Paladine W; Ruckdeschel JC; Goldstein JC; Olson JE; Jaski JW; Silvers SA; Hillinger S; Horton J
Cancer Treat Rep; 1979 Mar; 63(3):489-91. PubMed ID: 85494
[No Abstract] [Full Text] [Related]
18. [Chemotherapy in squamous cell carcinoma of the oral cavity].
Snow GB
Ned Tijdschr Tandheelkd; 1974 Sep; 81(8):315-8. PubMed ID: 4139671
[No Abstract] [Full Text] [Related]
19. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
[No Abstract] [Full Text] [Related]
20. Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388).
Luce JK; Thurman WG; Isaacs BL; Talley RW
Cancer Chemother Rep; 1970 Apr; 54(2):119-24. PubMed ID: 4334086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
